IN-VITRO EFFECTS OF RECOMBINANT HUMAN GRANULOCYTE-MACROPHAGE COLONY-STIMULATING FACTOR (RHGM-CSF) ON POLYMORPHONUCLEAR CELL (PMN) AND MONOCYTE (MO) FUNCTIONAL CAPACITIES IN OVARIAN-CANCER PATIENTS VERSUS HUMANVOLUNTEERS
M. Altamura et al., IN-VITRO EFFECTS OF RECOMBINANT HUMAN GRANULOCYTE-MACROPHAGE COLONY-STIMULATING FACTOR (RHGM-CSF) ON POLYMORPHONUCLEAR CELL (PMN) AND MONOCYTE (MO) FUNCTIONAL CAPACITIES IN OVARIAN-CANCER PATIENTS VERSUS HUMANVOLUNTEERS, Immunopharmacology and immunotoxicology, 19(4), 1997, pp. 437-449
Human polymorphonuclear cells (PMN) and monocytes (MO) from four ovari
an cancer patients and seventeen normal donors were in vitro pretreate
d with different concentrations (25, 50 and 100IU, respectively) of rh
GM-CSF. Phagocytosis and killing of PMN and MO as well as PMN polariza
tion were evaluated in cancer patients before treatment (TO) and at th
e end of each chemotherapeutic cycle (T1, T2, T3 and T4, respectively)
in comparison with normal donors. RhGM-CSF did not affect phagocytosi
s and killing of PMN and MO. On the other hand, this cytokine was per
se endowed with the capacity to enhance PMN polarization in both cance
r patients (at T2 interval) and normal donors.